There is one clinical trial.
The purpose of the Chinese PD-SNCA Registry(CPD-SNCAR) is to develop a database of patients of Parkinson's disease with a-synuclein (SNCA) gene variants in mainland China.
However, some polymorphisms of SNCA gene such as rs894278 and rs11931074 can affect the risk of sporadic PD.
Description: Establish the database of Parkinson's disease with SNCA variants in mainland China.Measure: Database of Parkinson's disease with SNCA variants Time: 10 years
Description: Characterize the clinical feature in patients of Parkinson's disease with SNCA variantsMeasure: Clinical feature Time: 10 years